LA SETA CATAMANCIO, SIMONA
 Distribuzione geografica
Continente #
EU - Europa 750
NA - Nord America 523
AS - Asia 225
SA - Sud America 6
AF - Africa 2
OC - Oceania 1
Totale 1.507
Nazione #
US - Stati Uniti d'America 500
GB - Regno Unito 343
SE - Svezia 122
CN - Cina 90
DE - Germania 68
IT - Italia 63
UA - Ucraina 43
TR - Turchia 40
SG - Singapore 36
KR - Corea 28
IE - Irlanda 24
CA - Canada 23
IN - India 21
RU - Federazione Russa 21
FR - Francia 17
EU - Europa 16
FI - Finlandia 16
NL - Olanda 14
CO - Colombia 6
GR - Grecia 6
HK - Hong Kong 6
RO - Romania 5
BE - Belgio 2
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
PL - Polonia 2
AU - Australia 1
IL - Israele 1
IR - Iran 1
Totale 1.523
Città #
Southend 322
Chandler 94
Wilmington 30
Princeton 29
Woodbridge 29
Jacksonville 28
Beijing 26
Milan 26
Dublin 24
Redmond 23
Seattle 22
Nanjing 18
Toronto 17
Ann Arbor 16
Fairfield 15
Singapore 15
Ashburn 14
Dearborn 14
Kent 14
Roxbury 14
Somerville 14
Sakarya 13
Bengaluru 11
Boardman 11
Des Moines 11
Mountain View 10
Auburn Hills 8
Serra 8
Mumbai 7
Andover 6
Athens 6
Bogotá 6
Fremont 6
Hong Kong 6
Houston 6
Jinan 6
Ottawa 6
Shenyang 6
Grafing 5
Los Angeles 5
Pisa 5
Cambridge 4
Chicago 4
Nürnberg 4
Palaiseau 4
Phoenix 4
Changsha 3
Helsinki 3
Shanghai 3
Al Mansurah 2
Baotou 2
Bitonto 2
Brussels 2
Hangzhou 2
Hebei 2
Hefei 2
Jakarta 2
Ningbo 2
San Diego 2
Tianjin 2
Verona 2
Zhengzhou 2
Arese 1
Bergamo 1
Brentwood 1
Brisbane 1
Eitensheim 1
Fuzhou 1
Guangzhou 1
Jiaxing 1
Lanzhou 1
Lecce 1
London 1
Margão 1
Nanchang 1
Noginsk 1
Preston 1
Pskov 1
Redwood City 1
Roseville 1
Seoul 1
Shaoxing 1
Siena 1
Taizhou 1
Tel Aviv 1
Trenton 1
Warsaw 1
Totale 1.032
Nome #
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects 192
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection : in vitro studies of mixed virus infections 157
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation 156
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine 143
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors 139
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs 116
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215 108
In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure 101
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine 95
Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase 91
Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES 86
Rapid onset of M184V mutation and phenotypic resistance to stavudine in zidovudine pre-treated HIV-1-infected individuals receiving the therapeutic regimens zidovudine plus lamivudine or stavudine plus lamivudine 84
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure 81
In vitro inhibition of HIV-1 by Met-SDF-1β alone or in combination with antiretroviral drugs 49
Totale 1.598
Categoria #
all - tutte 3.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020169 19 10 15 7 11 13 16 9 18 32 13 6
2020/2021221 12 11 27 1 19 10 13 21 36 10 54 7
2021/2022149 17 14 3 3 1 2 8 13 22 22 4 40
2022/2023249 19 35 21 42 31 49 1 21 17 0 10 3
2023/2024100 3 12 4 2 29 4 1 6 0 15 11 13
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 1.598